Citizens Jmp began coverage on shares of Slide Insurance (NASDAQ:SLDE - Free Report) in a research report released on Monday morning, Marketbeat reports. The brokerage issued a strong-buy rating and a $25.00 target price on the stock.
Several other equities analysts have also commented on SLDE. Keefe, Bruyette & Woods raised shares of Slide Insurance to a "hold" rating and set a $20.00 price objective for the company in a research report on Monday. Citigroup began coverage on Slide Insurance in a research note on Monday. They issued an "outperform" rating for the company. Morgan Stanley initiated coverage on Slide Insurance in a report on Monday. They set an "equal weight" rating and a $19.00 target price for the company. Barclays assumed coverage on Slide Insurance in a research report on Monday. They issued an "overweight" rating and a $25.00 target price on the stock. Finally, Piper Sandler initiated coverage on shares of Slide Insurance in a research report on Sunday. They set an "overweight" rating and a $25.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $23.17.
Check Out Our Latest Stock Analysis on Slide Insurance
Slide Insurance Trading Down 1.3%
Slide Insurance stock traded down $0.25 during midday trading on Monday, reaching $18.65. The company's stock had a trading volume of 222,795 shares, compared to its average volume of 1,151,176. Slide Insurance has a 52-week low of $17.30 and a 52-week high of $25.90.
Insider Activity
In related news, Director Robert Gries, Jr. sold 358,457 shares of the company's stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $15.81, for a total transaction of $5,667,205.17. Following the completion of the transaction, the director owned 2,031,265 shares in the company, valued at $32,114,299.65. This represents a 15.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stephen L. Rohde sold 11,082 shares of Slide Insurance stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $15.81, for a total value of $175,206.42. Following the completion of the sale, the director owned 9,335 shares in the company, valued at approximately $147,586.35. The trade was a 54.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 427,482 shares of company stock worth $6,758,490 over the last three months.
Institutional Trading of Slide Insurance
An institutional investor recently bought a new position in Slide Insurance stock. Opal Wealth Advisors LLC bought a new position in shares of Slide Insurance Holdings, Inc. (NASDAQ:SLDE - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,469 shares of the company's stock, valued at approximately $53,000.
Slide Insurance Company Profile
(
Get Free Report)
Launched in 2021, we are a technology enabled, fast-growing, coastal specialty insurer. We focus on profitable underwriting of single family and condominium policies in the property and casualty (“P&C”) industry in coastal states along the Atlantic seaboard through our insurance subsidiary, Slide Insurance Company (“SIC”).
Featured Articles

Before you consider Slide Insurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Slide Insurance wasn't on the list.
While Slide Insurance currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.